tbuckley/cabot-search huggingface dataset:
Impact of Allelic State on Overall Survival in <i>TP53-</i>mutant Acute Myeloid Leukemia (AML) and Higher Risk Myelodysplastic Syndromes (HR-MDS)
Authors: Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan G. Thompson, Daniel Lopes de Menezes, Shelonitda Rose, Isaac W. Boss, Stephanie Halene, Torsten Haferlach, Brian Fox, Amer M. Zeidan
Journal: Blood (2022)
Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys
Authors: Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Victoria Potter, Ibrahim Yakoub-Agha, Nathalie Fegueux, Michael Daskalakis, Matthew P. Collin, Peter Dreger, Nicolaus Kröger, Urs Schanz, Adrian Bloor, Arnold Ganser, Caroline Besley, Gerald Wulf, Urban Novak, Ivan Moiseev, Helene Schoemans, Grzegorz W Basak, Christian Chabannon, Anna Sureda, Bertram Glass, Zinaida Peric
Journal: Blood (2022)
Safety and Survival Outcomes in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-Based or Non-Lenalidomide-Based Treatments in the Real-World MM-034 Study
Authors: Michele Cavo, Sujith Dhanasiri, Valerio De Stefano, Angel Ramírez Payer, Martin Wiesholzer, Yvonne Tromp, Meegahage Ratnakanthi Perera, Valentine Richez-Olivier, Maciej Gil, David Bernasconi, Barbara Gamberi
Journal: Blood (2022)
De Novo Hematopoiesis from the Fetal LUNG
Authors: Anthony K Yeung, Carlos Villacorta-Martin, Jonathan Lindstrom-Vautrin, Anna C Belkina, Kim Vanuytsel, Todd Dowrey, Alexandra B Ysasi, Vladimir Vrbanac, Gustavo Mostoslavsky, Alejandro Balazs, George J Murphy
Journal: Blood (2022)
Duration of ≥MR4 Is the Best Predictor for a Successful 1st Treatment-Free Remission (TRF1) Attempt in CML Patients Treated with Tyrosine Kinase Inhibitors (TKI); Long-Term Follow-up of a Large Cohort of Patients Including a Cohort Undergoing a 2nd Tfr (TFR2) Attempt
Authors: James Anthony Schwarer, Anthony Schwarer
Journal: Blood (2022)
Effects of Isoquercetin on Plasma Protein Disulfide Isomerase Activity and Extracellular Vesicle Tissue Factor Antigen/Activity in Sickle Cell Disease
Authors: Bindu Parachalil Gopalan, Maria A.A. Lizarralde-Iragorri, Anna Conrey, Mai Hill, Brenda Merriweather, Jennifer Brooks, Ruth Pierre Charles, Eveline Gwaabe, Rafael Villasmil, Neal Jeffries, Arun S. Shet
Journal: Blood (2022)
Super-Enhancer-Driven PIM Kinase Upregulation in Multiple Myeloma Maintains the Plasma Cell-Specific Oncogenic and Microenvironmental Circuits, and Can be Efficiently Targeted By the Pan-PIM Inhibitor MEN1703
Authors: Filip Garbicz, Sonia Debek, Anna Szumera-Ciećkiewicz, Joanna Barankiewicz, Dorota Komar, Michał Pawlak, Aleksandra Matrejek, Thorsten Stuehmer, Aleksander Salomon-Perzynski, Agata Malenda, Julia Ostrowska, Julia Dudkiewicz, Krzysztof Brzózka, Tomasz Rzymski, Daniela Bellarosa, Ewa Lech-Marańda, Monika Prochorec-Sobieszek, Zofia Pilch, Dominika Nowis, Jakub Golab, Helen Tanton, Teru Hideshima, David M. Dorfman, Irena Misiewicz-Krzeminska, Tomasz Sewastianik, Ruben D. Carrasco, Maciej Szydlowski, Przemyslaw Juszczynski
Journal: Blood (2022)
Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial
Authors: Chunyan Xiao, Yao Ding, Chensi Zeng, Lingqian Zhang, Bingling Guo, Yingyu Nan, Yao Liu
Journal: Blood (2022)
Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group
Authors: Chezi Ganzel, Yakir Moshe, Itai Levi, Boaz Nachmias, Sigal Tavor, Jonathan Canaani, Tsila Zuckerman, Doaa Okasha, Ilana Hellmann, Tamar Tadmor, Najib Dally, Galia Stemer, Raanan Cohen, Jenia Berelovich, Noa Rivlin, Neta Frankel, Moshe Grunspan, Keren Ofek, Yishai Ofran, Ofir Wolach
Journal: Blood (2022)
Handling of Allogeneic HPC Grafts in European Transplant Centers during the COVID-19 Pandemic - a Survey from the Infectious Diseases and Cellular Therapy &amp; Immunobiology Working Parties of the EBMT
Authors: Nina Worel, Per T Ljungman, Isabel Sánchez-Ortega, Jorinde D Hoogenboom, Nina S Knelange, Inge CM Verheggen, Dirk-Jan Eikema, Annalisa Ruggeri, Jurgen Kuball, Diana Averbuch, Rafael De La Camara, Christian Chabannon
Journal: Blood (2022)
A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia with <i> <i>FLT3-ITD</i> </i> Mutation
Authors: Lei-Ming Cao, Ya-Lan Zhou, Ming-Yue Zhao, Li-Xia Liu, Hao Jiang, Ying-Jun Chang, Qian Jiang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo-Rui Ruan
Journal: Blood (2022)
Single Institution Observational Study of Risk-Adapted Therapy for Children with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia
Authors: Yixin Hu, Li Gao, Peifang Xiao, Hailong He, Yi Wang, Liyan Fan, Shengqin Cheng, Jing Ling, Jie Li, Junjie Fan, Yanhua Yao, Xin Ding, Jian Pan, Jun Lu, Raul C. Ribeiro, Shaoyan Hu
Journal: Blood (2022)
A Phase 1/2 Study of INCB000928 As Monotherapy or Combined with Ruxolitinib (RUX) in Patients (Pts) with Anemia Due to Myelofibrosis (MF)
Authors: Sanjay R Mohan, Stephen T Oh, Haris Ali, Anthony M. Hunter, Francesca Palandri, Betty Lamothe, Yi Cui, Francis Seguy, Amanda McBride, Michael Robert Savona, Jean-Jacques Kiladjian, Srdan Verstovsek
Journal: Blood (2022)
<i>UBASH3B</i> knockout Downregulates STAT1 Mediated Interferon Signalling and Megakaryocyte Related Genes in a <i>JAK2</i> V617F Positive MPN Model
Authors: Graeme M Greenfield, Deirdra Venney, Jaine Blayney, Mary Frances McMullin, Ken I Mills
Journal: Blood (2022)
Budget Impact Analysis of the Use of Gilteritinib for the Treatment of Patients with Relapsed or Refractory <i>FLT3</i>+ Acute Myeloid Leukaemia in Public Healthcare Institutions in Mexico
Authors: Ana Polanco, Estefanía Serrano, Luciana Saturnino, Barbara Flores, Belkis Monsalve, Bhavik J. Pandya
Journal: Blood (2022)
Targeting of G3BP2 Refines Prognosis and Synergizes with Venetoclax in Acute Myeloid Leukemia
Authors: Zhixiang Chen, Yuanhua Cai, Xiaolin Lai, Xiaofan Li, Lili Pan, Xuechun Wang, Fuquan Tu, Luya Ye, Yang Li, Shaoyuan Wang
Journal: Blood (2022)
Real-World Data Analysis of the Molecular Response Kinetics within the Two First Years of the RELMC-NOVA Study in Newly Diagnosed Spanish CML-CP Patients Treated with Tirosin Kinasa Inhibitors (TKIs) in First Line
Authors: Luis Felipe Casado Montero, Nuria Garcia-Ormeña, Manuel Perez Encinas, Santiago Osorio-Prendes, Francisca Ferrer Marin, Miguel Sagüés, Valentín Garcia-Gutiérrez, Fernando Marco De Lucas, Concepcion Boque, Soledad Noya, María Teresa Gomez Casares, Natalia Estrada, Maria Angeles Goñi, Angel Ramírez Payer, Maria Jose Requena, Sunil Lakhwani, Marcio Miguel Andrade Campos, Natalia De las Heras, María Ángeles Foncillas, Juan Luis Steegmann
Journal: Blood (2022)
Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real World Evidence
Authors: Sandra Cohen, Nadia M. Bambace, Imran Ahmad, Linda J. Burns, Jean Roy, Silvy Lachance, Léa Bernard, Jean-Sébastien Delisle, Denis-Claude Roy, Thomas L. Kiss, Olivier Veilleux, Mei-Jie Zhang, Xiao-Ying Tang, Guy Sauvageau
Journal: Blood (2022)
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
Authors: Adrian Mosquera Orgueira, Manuel Perez Encinas, Alberto Hernández Sánchez, Teresa González, Eduardo Arellano-Rodrigo, Javier Martinez Martínez Elicegui, Angela Villaverde Ramiro, Jose Maria Raya Sanchez, Rosa Ayala, Francisca Ferrer Marin, Maria Laura Fox, Patricia Velez Tenza, Elvira Mora Casterá, Blanca Xicoy, Maria Isabel Mata Vazquez, María García Fortes, Anna Angona, Beatriz Cuevas, María Alicia Senin, Angel Ramírez Payer, María José Ramírez, Raul Perez Lopez, Sonia González de Villambrosia, Clara Martínez, María Teresa Gómez-Casares, Carmen Garcia-Hernandez, Mercedes Gasior Kabat, Beatriz Bellosillo, Juan Luis Steegmann, Alberto Alvarez-Larran, Jesús M Hernández Rivas, Juan Carlos Hernandez Boluda
Journal: Blood (2022)
Health-Related Quality of Life and Disease Impacts in Adults with Transfusion-Dependent β-Thalassemia: Preliminary Results from the Global Longitudinal Survey
Authors: Nanxin Li, Jennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, Laurice Levine, Neelam Dongha, Zahra Pakbaz, Fikret Kaan Oran, Kamran Iqbal, Farrukh Shah, Antony P. Martin
Journal: Blood (2022)
Mogamulizumab-Associated Rash (MAR) Correlates with Longer Progression Free Survival in Cutaneous T Cell Lymphoma (CTCL)
Authors: Bei Hu, Shebli Atrash, Leah Cohen, Stefan K. Barta, Yumeng Zhang, Lubomir Sokol, Amy Ayers, Luis E Malpica Castillo, Steven R Hwang, N. Nora Bennani, David Wada, Aung M Tun, Tamara K. Moyo, Nilanjan Ghosh, Michi M Shinohara
Journal: Blood (2022)
<i>Novel Disease-Causing Mutations in UBA1 Reveal Disease Mechanisms in Bone Marrow Failure and Inflammation</i>
Authors: Jason C Collins, Nicholas Balanda, Samuel J Magaziner, Maya English, Daniela Ospina Cardona, Mrinal M. Patnaik, Benjamin Terrier, Olivier Kosmider, Achim Werner, David B. Beck
Journal: Blood (2022)
Drivers of Deep Molecular Response and Outcomes in Patients with Core Binding Factor Acute Myeloid Leukemia
Authors: Somedeb Ball, Akriti G Jain, Parth C. Patel, Chen Wang, Luis E. Aguirre, Mohammad O Hussaini, Onyee Chan, Seongseok Yun, Andrew Kuykendall, Eric Padron, Kendra Sweet, Jeffrey E. Lancet, Rami S. Komrokji, David A. Sallman
Journal: Blood (2022)
Neutrophil-to-Lymphocyte Ratio As a Predictor of All-Cause Mortality in the General Population and Patients with Myeloproliferative Neoplasms
Authors: Morten Kranker Kranker Larsen, Vibe Skov, Lasse Kjær, Henrik E. Poulsen, Christina S. Eickhardt-Dalbøge, Trine A. Knudsen, Sarah F. Christensen, Anders L. Sørensen, Marie H. Kristiansen, Troels Wienecke, Rasmus K. Pedersen, Morten Andersen, Johnny T. Ottesen, Thomas Stiehl, Christina Ellervik, Hans Carl Hasselbalch
Journal: Blood (2022)
The Role of ADAMTS13 Activity Levels on Disease Exacerbation or Relapse in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of the Phase 3 HERCULES and Post-HERCULES Studies
Authors: Johanna A. Kremer Hovinga Strebel, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knoebl, Flora Peyvandi, Spero Cataland, PAUL Coppo, Umer Khan, Laurel A. Menapace, Ana Paula Marques, Sriya Gunawardena, Marie Scully
Journal: Blood (2022)
Chemotherapy-Based Regimes Increase Karyotype Complexity of Del(11q) CLL Cells and Impact the Response to Subsequent Ibrutinib Treatment
Authors: Miguel Quijada Álamo, Laura Z. Rassenti, Emanuela M. Ghia, Tuan Tran, Monica Spydell, Elsa Molina, Claudia Pérez Carretero, Luis A. Corchete, Teresa González, Jesús María Hernández-Rivas, Thomas J. Kipps
Journal: Blood (2022)
Minimal Residual Disease Monitoring By Targeted Mass Spectrometry Allows Early Relapse Detection in Multiple Myeloma
Authors: Somayya Noori, Charissa Wijnands, Pieter Langerhorst, Simon Nadal, Vincent Bonifay, Christoph Stingl, Cyrille Touzeau, Theo Luider, Thomas Dejoie, Johannes Jacobs, Martijn Vanduijn
Journal: Blood (2022)
Indolent Acute Myeloid Leukemia with Long Survival in Patients Treated with Best Supportive Care Only: A Pethema Registry Study
Authors: Jorge Labrador, Josefina Serrano, Laura Torres, Evelyn Acuña-Cruz, Jose A. Perez-Simon, Maria Lopez-Pavia, Gabriela Rodriguez Macias, Carmen Botella, Carlos Rodriguez, Pilar Martinez Sanchez, Maria Luz Amigo, Maria Victoria Cuevas, Teresa Bernal del Castillo, María Carmen Montes, Celina Benavente, Juan Ignacio Rodriguez-Gutierrez, Mar Tormo, Raimundo García-Boyero, Aurelio Lopez Martínez, Rafael Lluch Garcia, Jesús Lorenzo Algarra, Esperanza Lavilla, David Martinez-Cuadron, Miguel A. Sanz, Pau Montesinos
Journal: Blood (2022)
Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease
Authors: Christine E. Ryan, Benjamin L. Lampson, Svitlana Tyekucheva, Liam R. Hackett, Yue Ren, Samantha J. Shupe, Stacey M. Fernandes, Jennifer L. Crombie, Samuel Ng, Austin I. Kim, Inhye E. Ahn, Matthew J Weinstock, Samantha Pazienza, Josie S. Montegaard, Victoria Patterson, Caron A. Jacobson, Ann S. LaCasce, Philippe Armand, David C. Fisher, Jon E. Arnason, Steve Lo, Adam Olszewski, Jennifer R. Brown, Matthew S. Davids
Journal: Blood (2022)
Phase 1/2a Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of Pxs-5505 in Patients with Primary, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis
Authors: Ross Baker, Jana Baskar, Brett Charlton, Gabriela S. Hobbs, Wolfgang Jarolimek, Sung-Eun Lee, Lucia Masarova, Anne-Marie Watson
Journal: Blood (2022)
Validation of the CIBMTR Scoring System in Predicting Early Relapse of Multiple Myeloma Post Autologous Hematopoietic Cell Transplant
Authors: Hussein Awada, Adel Hajj Ali, Danai Dima, Lauren M. Granat, Michael Sheu, Puneet Dhillon, Mikhaila Rice, Heena P Kurish, Louis S. Williams, Faiz Anwer, Jack Khouri
Journal: Blood (2022)
Dynamics of Response and Response Factors in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs) in the Phase 3 Ascembl Study
Authors: Timothy Hughes, Delphine Rea, Carla Boquimpani, Yosuke Minami, Michael Mauro, Jorge E. Cortes, Jane F. Apperley, Valentín García Gutiérrez, Shruti Kapoor, Alex Allepuz, Sarah Quenet, Yifan Zhang, Andreas Hochhaus
Journal: Blood (2022)
Dose-Adjusted EPOCH Versus Hypercvad As Initial Treatment for Adults with Acute Lymphoblastic Leukemia (ALL): A Retrospective Matched Cohort Comparison
Authors: Lucas Zarling, Philip Stevenson, Lorinda A. Soma, Christen H. Martino, Mary-Elizabeth M. Percival, Anna B. Halpern, Cristina Ghiuzeli, Pamela S. Becker, Vivian G. Oehler, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Elihu H. Estey, Ryan D. Cassaday
Journal: Blood (2022)
Digital Droplet PCR for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia Using IG/TR Genes and <i>BCR/ABL1</i> as Markers. Preliminary Results of a Comparative Analysis
Authors: Marco Beldinanzi, Irene Della Starza, Deborah Cardinali, Vittorio Bellomarino, Loredana Elia, Mabel Matarazzo, Mariangela Di Trani, Sabina Chiaretti, Robin Foà
Journal: Blood (2022)
Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma
Authors: Danny Luan, Chen Zhengming, Lasse Hjort Jakobsen, Matthew J. Maurer, Tarec Christoffer Christoffer El-Galaly, Loretta J. Nastoupil, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Izidore S. Lossos, Deborah M. Stephens, Thomas M. Habermann, Grzegorz S. Nowakowski, Nancy L. Bartlett, Jonathan W. Friedberg, Brad S. Kahl, John P. Leonard, Peter De Nully Brown, Karin E. Smedby, Mats Jerkeman, Peter Martin
Journal: Blood (2022)
Patient Characteristics and Survival Outcomes of Lenalidomide Exposed non- Refractory vs. Lenalidomide Refractory Multiple Myeloma Patients in the HONEUR Federated Data Network
Authors: Roman Hajek, Henrik Sliwka, Martin Stork, Ivan Spicka, Tomas Jelinek, Jakub Radocha, Alexandra Jungova, Jiri Minarik, Jan Soukup, Nolen Joy Perualila, Joris Diels, Michel van Speybroeck, Nichola Erler-Yates, João Mendes, Kai Strobel, Sébastien Wischlen, Maximilian Merz
Journal: Blood (2022)
Novel Home-Based Transfusion Model of Palliative Care in Malignant Hematology
Authors: Rabia Saleem, Kira MacDougall, Ayesha Hassan, Maria Siddiqui, Mohamad O. Khawandanah, Alexandra Ikeguchi, Adam S. Asch, Sami Ibrahimi, George B. Selby, Deepika Neelakantan, Barbara Ledford, Tuan N Le, Sara K. Vesely, Silas A Day, Stefani D Madison, Bryan Struck, John Armitage, Ryann Nipp, Sarah Minor, Carrie Yuen, Jennifer Holter-Chakrabarty
Journal: Blood (2022)
Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis
Authors: Ricardo D Parrondo, Lindsay Brooke Gardner, Mohamad Alhaj Moustafa, Vivek Roy, Taimur Sher, Ahsan Rasheed, Rahma M Warsame, Jeremy T. Larsen, Wilson I. Gonsalves, Taxiarchis Kourelis, Prashant Kapoor, Rafael Fonseca, Asher Chanan-Khan, Sikander Ailawadhi
Journal: Blood (2022)
Interplay of <i>TP53</i> Allelic State, Blast Count and Karyotype on Survival of Patients with AML and MDS
Authors: Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood (2022)
Retrospective Analysis of Prognostic Factors and Survival in Multiple Myeloma Patients Aged 65 Years or Older at Diagnosis in a Real-Life Setting and a Proposed New Staging System
Authors: Ali Tunc, Murad Guliyev, Tuba Özkan Tekin, Selin Kucukyurt, Umut Yilmaz, Eda Kantarci, Damla Ortaboz, Tuğrul Elverdi, Ahmet Emre Eşkazan, Şeniz Öngören, Muhlis Cem Ar, Zafer Başlar, Yildiz Aydin, Ayse Salihoglu
Journal: Blood (2022)
R-CHOP Versus R-EPOCH in Primary Mediastinal Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
Authors: Mohammad Ebad Ur Rehman, Rabia Ali, Jawad Basit, Usman Ali Akbar, Sajeel Saeed, Maurish Fatima, Larabe Farrukh, Adeel Masood, Ahmad Iftikhar, Muhammad Husnain, Hamza Hassan, Muhammad Salman Faisal, Faiz Anwer
Journal: Blood (2022)
DEK-NUP214 Acute Myeloid Leukemia Depends on CRM1 In Vivo
Authors: Fiorella Charles Cano, Arnold Kloos, Rucha Yeshwanta Hebalkar, Razif Gabdoulline, Thomas Fangmann, Yosef Landesman, Konstanze Döhner, Halyna R. Shcherbata, Arnold Ganser, Michael Heuser
Journal: Blood (2022)
Phase 2 Study of ASTX727 (cedazuridine/decitabine) Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Previously Untreated, Elderly Patients with AML Unfit for Chemotherapy
Authors: Tareq Abuasab, Guillermo Garcia-Manero, Nicholas Short, Yesid Alvarado, Ghayas C. Issa, Rubiul Islam, Abhishek Maiti, Musa Yilmaz, Nitin Jain, Lucia Masarova, Steven M. Kornblau, Elias Jabbour, Naveen Pemmaraju, Guillermo Montalban-Bravo, Sherry A. Pierce, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi
Journal: Blood (2022)
Use of Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Free Light Chain Assessment for the Diagnosis and Monitoring of Systemic Immunoglobulin Light Chain (AL) Amyloidosis
Authors: Joshua Bomsztyk, Sriram Ravichandran, Hannah Victoria Giles, Oscar Berlanga, Stephen Harding, Jahanzaib Khwaja, Shameem Mahmood, Brendan Wisniowski, Oliver C Cohen, Darren Foard, Janet Gilbertson, Ana Martinez De Azcona Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian D Gillmore, Helen J Lachmann, Guy Pratt, Ashutosh D. Wechalekar
Journal: Blood (2022)
Assessing Immune Response to 3rd Dose of COVID-19 Vaccine Series in Patients Undergoing Cancer Treatment at University Medical Center- New Orleans
Authors: Anh Q. Nguyen, Amber J Trauth, Aneesha Ananthula, Katharine Thomas, Shyam Mani, Monique Germain, Donnell D. White, Brian C. Boulmay, Michael Hagensee
Journal: Blood (2022)
Real-World Experience of Venetoclax Combination Therapy in Patients with Acute Myeloid Leukemia (AML): A Single-Institution Retrospective Study in a Middle-Income Country
Authors: Natalia Aránguiz, Ximena Valladares, Javiera Donoso, Sebastian Ignacio Ewoldt, Daniel Ernst, Joaquin Diaz, Matias Sanchez
Journal: Blood (2022)
Intensive Therapy for NPM1 Mutant AML Patients: Negative Impact of <i>FLT3-ITDhigh</i>but Not <i>FLT3-ITDlow</i> and <i>FLT3-TKD</i> and Role of Transplant in Patients over 60 Years of Age
Authors: Eric S. Winer, Yael Flamand, Rory Michael Shallis, Jessica M. Stempel, Aaron D Goldberg, Maximilian F. Stahl, Anand Ashwin Patel, Adam S Duvall, Yasmin Abaza, Timothy Seijung Oh, Karen Ma, Talha Badar, Mark R. Litzow, Vamsi Kota, Danielle Bradshaw, Hari S. Raman, Marlise R. Luskin, Richard M. Stone, Daniel J. DeAngelo
Journal: Blood (2022)
Analysis of Patient-Level Data from 3 Cooperative Group Trials Confirms a Survival Advantage for <i>NPM1</i>m Patients Achieving MRD-Negative CR after Intensive Induction
Authors: Konstanze Döhner, Hartmut Döhner, Daniela Weber, Silke Kapp-Schwoerer, Amanda Gilkes, Ian Thomas, Sean Johnson, Nicola Potter, Yana Bevan, Jad Othman, Nigel H. Russell, Christoph Röllig, Christian Thiede, Martin Bornhaeuser, Thomas Oellerich, Jenna Elder, Luis A. Carvajal, Zung To, Jorge DiMartino, Richard Dillon
Journal: Blood (2022)
Prediction of Resistance to Hydroxyurea Therapy in Patients with Polycythemia Vera: A Machine Learning Study (PV-AIM)
Authors: Srdan Verstovsek, Florian H. Heidel, Valerio De Stefano, Mike Zuurman, Kenneth Bryan, Armita Afsharinejad, Jean-Jacques Kiladjian
Journal: Blood (2022)
Impact of Allele-Level HLA-Matching on Outcomes after Double Unrelated Cord Blood Transplantation in Adults with Malignant Diseases
Authors: Giancarlo Fatobene, Livia Mariano, Fernanda Volt, Frederico Rafael Moreira, Jan J. Cornelissen, Didier Blaise, Etienne Daguindau, Nathalie Fegueux, Régis Peffault de Latour, Hanadi Rafii, Monica M Rivera-Franco, Chantal Kenzey, Graziana Maria Scigliuolo, Barbara Cappelli, Annalisa Ruggeri, Eliane Gluckman, Vanderson Rocha
Journal: Blood (2022)
A Clinically Practicable Approach to Predict <i>TP53</i> Allelic Configurations in Myeloid Neoplasia
Authors: Waled Bahaj, Tariq Kewan, Carmelo Gurnari, Arda Durmaz, BEN Ponvilawan, Ishani Pandit, Yasuo Kubota, Olisaemeka Ogbue, Mai Aly, Yazan F. Madanat, Taha Bat, Suresh Kumar Balasubramanian, Minako Mori, Manja Meggendorfer, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood (2022)
Evaluation of a Gene Signature Related to Thrombotic Manifestations in Antiphospholipid Syndrome
Authors: Bruna Cardoso Jacintho, Bruna M Mazetto, Bidossessi Wilfried Hounkpe, Ana Paula Rosa dos Santos, Camila de Oliveira Vaz, José Diogo Oliveira, Erich V De Paula, Fernanda Andrade Orsi
Journal: Blood (2022)
Fast-Track Measurable Residual Disease Detection By Multiparametric Flow Cytometry in Acute Myeloid Leukemia before Allogeneic Hematopoietic Cell Transplantation
Authors: Maximilian Alexander Röhnert, Michael Kramer, Jonas Schadt, Philipp Ensel, Christoph Röllig, Johannes Schetelig, Friedrich Stölzel, Martin Bornhaeuser, Uta Oelschlägel, Malte von Bonin
Journal: Blood (2022)
Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
Authors: Leling Xie, Runxia Gu, Xue Yang, Shaowei Qiu, Yingxi Xu, Junli Mou, Ying Wang, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Jianxiang Wang
Journal: Blood (2022)
HLA Evolutionary Divergence (HED) Informs the Effect of HLA-B-Loci Mismatch on Relapse and Disease Free Survival after Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)
Authors: Melhem Solh, Michael T Aubrey, Xu Zhang, Asad Bashey, Brian M Freed, Christina L Roark, Lizamarie Bachier-Rodriguez, Lawrence E. Morris, H. Kent Holland, Scott R. Solomon
Journal: Blood (2022)
Polatuzumab- Rituximab with or without Bendamustine As Second-Line Therapy for Relapsed Refractory Large B-Cell Lymphomas: Single Center Experience
Authors: Ariel Perez Perez, Shreya Saxena, Tiba Al Sagheer, Muni Rubens, Talia Zahra, George Nahas, Alex V. Mejia Garcia, Lyle Feinstein, Lisa Reale, Marco Andres Ruiz, Peter L. Citron, Atulya Khosla, Manmeet Ahluwalia, Guenther Koehne, Yuliya P.L. Linhares
Journal: Blood (2022)
Identification of IL-4 As a Key Regulator of CAR T-Cell Exhaustion Using Functional Genomics and Correlates of the Zuma-1 Clinical Trial
Authors: Carli M. Stewart, Michelle J. Cox, Reona Leo Sakemura, Ekene J. Ogbodo, Ismail Can, Claudia Manriquez-Roman, Kun Yun, Olivia Sirpilla, James H. Girsch, Truc Huynh, Elizabeth L. Siegler, Jenny J Kim, Mike Mattie, Nathalie Scholler, Simone Filosto, Saad S. Kenderian
Journal: Blood (2022)